Lv1
68 积分 2021-07-01 加入
ERN ReCONNET-SLICC-SLEuro consensus on the therapeutic management of rare systemic lupus erythematosus manifestations (part 2)
1个月前
已关闭
ERN ReCONNET–SLICC–SLEuro consensus on the therapeutic management of rare systemic lupus erythematosus manifestations (part 2)
1个月前
已关闭
Low-dose oral nicotinamide mononucleotide for immune thrombocytopenia: a phase 1/2 trial
2个月前
已完结
Preclinical Characterization of Pharmacologic NAD+ Boosting as a Promising Therapeutic Approach in Rheumatoid Arthritis
2个月前
已完结
Realizing the promise of CAR-T cell therapies for autoimmune diseases
2个月前
已完结
Pregnancies in Patients with Autoimmune Disease Receiving CAR T-Cell Therapy
2个月前
已完结
Update on the pathophysiology and treatment of primary Sjögren syndrome
2个月前
已完结
The autoantigen TRIM21 assembles proinflammatory immune complexes after lytic cell death
2个月前
已完结
Ameliorating hydroxychloroquine induced retinal toxicity through cerium oxide nanoparticle treatments
3个月前
已完结
Repurposing leflunomide and hydroxychloroquine to treat Sjögren's disease (RepurpSS-II): a randomised, double-blind, placebo-controlled, phase 2b trial
3个月前
已完结
皖公网安备34019202002308
